Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-18

Clinical Trial Update: Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial in HIV-infected South African patients comparing stavudine versus tenofovir, each combined with lamivudine and efavirenz, has been t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)
  • Lamivudine (lamivudine)
  • Tenofovir (Tenofovir)
  • stavudine (stavudine)

Snippet

Sponsor: University of Witwatersrand, South Africa | Conditions: Mitochondrial Toxicity, Metabolic Complications | Phase 4 | Status: TERMINATED